R
Robert Driscoll
Researcher at University of Lausanne
Publications - 7
Citations - 235
Robert Driscoll is an academic researcher from University of Lausanne. The author has contributed to research in topics: Cancer & Angiogenesis. The author has an hindex of 7, co-authored 7 publications receiving 231 citations. Previous affiliations of Robert Driscoll include ISREC.
Papers
More filters
Journal ArticleDOI
Tenascin‐W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients
Martin Degen,Florence Brellier,Susanne Schenk,Robert Driscoll,Khalil Zaman,Roger Stupp,Luigi Tornillo,Luigi Terracciano,Ruth Chiquet-Ehrismann,Curzio Rüegg,Walter Seelentag +10 more
TL;DR: The results reveal a clear association between elevated levels of tenascin‐W and the presence of cancer and warrant further studies to evaluate the potential value of serum and tissue tenascIn‐W levels as diagnostic, prognostic or monitoring biomarker in colorectal, breast and possibly other solid cancers.
Journal ArticleDOI
Monitoring multiple angiogenesis-related molecules in the blood of cancer patients shows a correlation between VEGF-A and MMP-9 levels before treatment and divergent changes after surgical vs. conservative therapy.
Khalil Zaman,Robert Driscoll,Robert Driscoll,Diane Hahn,Patricia Werffeli,Patricia Werffeli,Simon L. Goodman,J. Bauer,Serge Leyvraz,Ferdy J. Lejeune,Roger Stupp,Curzio Rüegg,Curzio Rüegg +12 more
TL;DR: Only VEGF‐A and MMP‐9 consistently correlated to each other, elevated CRP levels were associated with tumor burden, whereas sVEGF‐R1 increased after tumor removal in colorectal cancer.
Journal ArticleDOI
The quest for surrogate markers of angiogenesis: a paradigm for translational research in tumor angiogenesis and anti-angiogenesis trials.
TL;DR: It is necessary to identify and validate molecular, cellular and functional surrogate markers of angiogenesis to monitor activity and efficacy of anti-angiogenic drugs in patients and to identify new molecular targets and drugs, and to improve planning, monitoring and interpretation of future studies.
Journal ArticleDOI
Helper-dependent adenovirus vectors devoid of all viral genes cause less myocardial inflammation compared with first-generation adenovirus vectors.
Sylvain Fleury,Robert Driscoll,Eleonora Simeoni,Jean Dudler,Ludwig K. von Segesser,Lukas Kappenberger,Giuseppe Vassalli +6 more
TL;DR: HD vectors are as efficient as ΔE1 vectors at transducing the myocardium and vascular endothelium, while causing less myocardial inflammation, and may be superior to earlier-generation adenovirus vectors for cardiovascular gene therapy applications.
Journal ArticleDOI
Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo.
Daniel Cefai,Eleonora Simeoni,Kaethy Mujynya Ludunge,Robert Driscoll,Ludwig K. von Segesser,Lukas Kappenberger,Giuseppe Vassalli +6 more
TL;DR: It is shown that multiply attenuated, self-inactivating, lentiviral vectors transduce both proliferating and growth-arrested human umbilical vein ECs, human coronary artery ECs), and human coronary arteries smooth muscle cells, with high efficacy.